Cargando…
Solid-Phase Parallel Synthesis of Dual Histone Deacetylase-Cyclooxygenase Inhibitors
Multi-target drugs (MTDs) are emerging alternatives to combination therapies. Since both histone deacetylases (HDACs) and cyclooxygenase-2 (COX-2) are known to be overexpressed in several cancer types, we herein report the design, synthesis, and biological evaluation of a library of dual HDAC-COX in...
Autores principales: | Bachmann, Luisa M., Hanl, Maria, Feller, Felix, Sinatra, Laura, Schöler, Andrea, Pietzsch, Jens, Laube, Markus, Hansen, Finn K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920637/ https://www.ncbi.nlm.nih.gov/pubmed/36770730 http://dx.doi.org/10.3390/molecules28031061 |
Ejemplares similares
-
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy
por: Kraft, Fabian B., et al.
Publicado: (2023) -
Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profile
por: Selg, Christoph, et al.
Publicado: (2021) -
Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-hi]indoles and Their Potential Prodrugs
por: Laube, Markus, et al.
Publicado: (2019) -
CRISPR/Cas9 Mediated Knockout of Cyclooxygenase-2 Gene Inhibits Invasiveness in A2058 Melanoma Cells
por: Haase-Kohn, Cathleen, et al.
Publicado: (2022) -
Dual Inhibitors Against Topoisomerases and Histone Deacetylases
por: Seo, Young Ho
Publicado: (2015)